- Study protocol
- Open Access
Study protocol of Diabetes LEAP: a longitudinal study examining emotional problems in adolescents with type 1 diabetes and their parents/caregivers
BMC Pediatrics volume 19, Article number: 377 (2019)
Type 1 diabetes (T1D) is a chronic metabolic condition requiring intensive daily self-care to avoid both high and low blood glucose levels. Self-care and glycemic outcomes are particularly problematic in adolescence, a period known for its increased risk of emotional problems. However, the true scope of mood and anxiety disorders in adolescents with T1D is unknown. Earlier studies are limited by a small sample size, lack of diagnostic interview data, a focus on depression only, non-adolescent specific estimates, lack of information about parental emotional problems and/or a cross-sectional design. Diabetes LEAP is a two-year prospective observational cohort study examining (a) the prevalence and course of depression and anxiety in adolescents with T1D and their parents/caregivers, (b) the risk factors predicting the presence of these emotional problems, (c) their longitudinal relation with diabetes outcomes, and (d) the psychosocial care currently in place.
Adolescents (12–18 years) from 8 Dutch pediatric diabetes clinics are interviewed using the DISC-IV to establish the presence of mood and anxiety disorders in the previous 4 weeks, the previous 12 months, and lifetime. They also complete questionnaires, including CDI-2, GAD-7, and PAID-T. Parents/caregivers complete PHQ-9, GAD-7, and PAID-PR. Follow-up assessments take place after 1 and 2 years.
This longitudinal study with diagnostic interviews in a large cohort of adolescents with T1D in the Netherlands will provide much needed information regarding the prevalence and course of depression and anxiety in this group, thereby opening avenues for proper recognition, prevention and timely treatment.
Type 1 diabetes is an increasingly common and serious health problem
Type 1 diabetes (T1D) is among the most common chronic conditions in childhood, affecting more than one million children and adolescents worldwide and approximately 6000 young people in the Netherlands [1, 2]. It has been predicted that the number of young people with T1D will continue to increase [3, 4]. Having to deal with T1D can be challenging, not only for the children themselves but also for their families . The Diabetes Control and Complications Trial has shown the importance of optimal management of blood glucose levels in the prevention of complications , but this can only be achieved with complex daily self-management. This includes blood glucose monitoring and injecting insulin multiple times a day or using an insulin pump, while taking into account factors such as carbohydrate intake and physical activity.
Need for improved care and reduced psychosocial burden
Despite recent advancements in insulin-delivery and glucose-measurement technologies, glycemic outcomes remain suboptimal for the majority of young people with T1D, with less than one third achieving the international pediatric HbA1c target (< 7.5%/ 58 mmol/mol) . This will be even less when using the new target for children and adolescents of the International Society for Pediatric and Adolescent Diabetes (< 7% / 53 mmol/mol) . It is well known that psychosocial problems are an important barrier for further improvements in diabetes care . Psychosocial difficulties may interfere with the complex self-care activities and motivation of young people and their family, seriously impair diabetes management, and contribute to suboptimal glycemic outcomes . In turn, suboptimal HbA1c with concomitant high and fluctuating glucose values may impact psychosocial functioning. Thus, proper identification, diagnosis, and treatment of psychosocial issues and barriers are required to improve the diabetes care outcomes of young people with T1D. This is especially relevant for adolescents, as this group is particularly at risk for suboptimal glycemic outcomes [9, 10]. Reasons include hormonal changes, a mismatch between fully developed motor skills and ongoing cognitive maturity, conflicts between diabetes care and developmental tasks, as well as an increased vulnerability for the onset or worsening of emotional problems [11,12,13].
The exact scope of mood and anxiety disorders in adolescents with T1D is unknown
Having to manage a demanding and rather unpredictable condition such as T1D can lead to significant distress, including feelings of depression and anger, worries about complications, and negative social interactions . Young people with T1D also seem to have a 1.5 to 2 times increased risk of psychiatric conditions, including mood and anxiety disorders, compared to children without diabetes . However, the exact size of the problem in adolescents is still unclear, as the available studies have several important methodological limitations. Most importantly, the majority of studies have relied on self-report questionnaires to assess symptoms of depression and anxiety, e.g. [16,17,18], rather than using a structured diagnostic interview to determine the presence of a psychiatric disorder. Much of what self-report scales assess appears to be (subclinical) diabetes-specific emotional distress rather than psychopathology . The few studies that have used the diagnostic interview included less than 100 participants, did not distinguish between depression and anxiety, combined data from adolescents with data from children or young adults, or were conducted 20 years ago when diabetes treatment options were considerably different [20,21,22,23,24,25]. A recent Polish study among 207 children aged 8–18 years found that 4% had a current mood disorder and 16% had a current anxiety disorder . However, this study might not be representative of the adolescent T1D population at large, as it excluded young people with significant co-existing diseases and did not distinguish estimates for children and adolescents separately .
Information about the course of mood or anxiety disorders (and related care decisions) is scarce
As the majority of previous studies used a cross-sectional design, information with respect to the course of mood or anxiety disorders in adolescents with T1D is also scarce. Early data from small scale studies suggest that up to half of all young people with T1D will be confronted with a psychiatric disorder (for example a mood, anxiety, eating, or conduct disorder) at least once while growing up [20, 21]. Major depression appeared to be the most prevalent disorder, affecting approximately 28% of 92 American youth 10 years after the diagnosis of diabetes . In addition, almost one fifth of this sample developed an anxiety disorder . As a last limitation, studies that have determined the presence of a mood and/or anxiety disorder have not systematically assessed the care decisions that were subsequently taken. A high quality study is needed, establishing the prevalence and course of mood and anxiety disorders in a large cohort of adolescents with T1D, including their link with diabetes-specific distress, as well as a description of the treatment and follow-up that is provided.
Parental factors might be a very important, yet understudied topic
Caring for an adolescent with T1D is challenging, e.g. due to differences in views on diabetes management and goals, and poses parents and caregivers at additional risk for emotional distress [28, 29]. Approximately 20–30% of parents of children with T1D report clinically significant distress, defined as life or parenting stress, anxiety or depression . In the general population, parental emotional problems have been associated with increased risk of internalizing problems (such as anxiety or depression) in children [30,31,32]. In the context of T1D, parental emotional problems may not only have a direct negative effect on child mental health, but may also worsen diabetes management and glycemic outcomes [29, 33]. A continued level of parental involvement in diabetes care, adjusted to and stimulating the child’s self-efficacy beliefs, is one of the factors for successful diabetes outcomes in adolescence [34,35,36,37]. Emotional problems of parents may negatively interfere with their availability in diabetes care, either by under- or over involvement [38,39,40,41]. Even though parental emotional distress is common and has been associated with child distress and impaired diabetes management [21, 22, 29], it is infrequently included in (large) studies of children with T1D. Furthermore, longitudinal data on the course of these problems are currently lacking and emotional distress of parents/caregivers is not included as a standard risk factor in studies examining emotional problems in children with T1D.
Aim and design
Diabetes LEAP (Longitudinal study of Emotional problems in Adolescents with type 1 diabetes and their Parents) was designed as a two-year prospective study to determine the true scope of depression and anxiety in a large cohort of adolescents with T1D (12–18 years) and their parents/caregivers. Its aims are to:
Establish the prevalence and course of mood and anxiety disorders among adolescents with T1D and of elevated symptoms of depression and anxiety in parents/caregivers.
Describe treatment and follow-up, once the pediatrician has been informed of the presence of a mood or anxiety disorder.
Identify demographic, clinical and psychological risk factors associated with the occurrence of emotional problems in this group.
Examine the longitudinal relations of these problems with diabetes outcomes.
Participants and procedure
Eligible adolescents with type 1 diabetes (12–18 years) and the parent/caregiver primarily involved in diabetes care are approached for participation. Exclusion criteria are diabetes duration of < 6 months, insufficient mastery of the Dutch language, moderate to severe intellectual disability, or severe psychosocial circumstances interfering with participation, all based on medical records and pediatricians’ judgement. Participants are recruited from 8 pediatric diabetes clinics across the Netherlands, including the Diabeter clinics (locations: Deventer, Groningen, Rotterdam, Schiphol, Veldhoven), Albert Schweitzer hospital Dordrecht, Meander Medical Center Amersfoort, and Diabetes Centraal (St. Antonius hospital) Utrecht.
Eligible families receive an information package about study participation, asking them to read the materials before their next usual care visit. During this visit, the pediatrician discusses the study with the adolescent and both of his/her parents. Families who agree to participate complete written informed consent. Adolescents can participate (with consent from parents/caregivers), even if the parent/caregiver him−/herself does not want to participate. The parent/caregiver cannot participate if the adolescent declines. At a subsequent visit, the adolescent undergoes a structured diagnostic interview to assess the presence and history of mood and anxiety disorders. During the same visit, he/she completes a questionnaire regarding (potential risk factors for) emotional problems. Parents/caregivers answer similar questionnaires, either at home or in the clinic. Pediatricians of the research team then report the presence of disorders to the adolescent’s pediatrician, who later completes a questionnaire about the course of action that is taken.
For both adolescents and parents/caregivers, follow-up assessments take place after 1 and 2 years. Participants who miss the time window for the one-year follow-up due to frequent rescheduling are considered as participants in the two-year follow-up with a missing one-year follow-up assessment. Participants who decline participation in the one- year follow-up are asked if they may be approached for the two-year follow-up. Assessments are preferably conducted face-to-face; if it is not possible to schedule a visit, interviews are held over the phone or via Skype.
The study protocol has been approved for all study sites by the Medical Ethics Committee of the Máxima Medical Center (NL48232.015.14). The first participant was included on 14-1-2015; recruitment and follow-up assessments are ongoing.
Assessment of depression and anxiety in adolescents
At baseline and 1 and 2 year follow-up, the Dutch version of the Diagnostic Interview Schedule for Children (DISC-IV)  is used to establish the presence of mood and anxiety disorders in adolescents in the previous 4 weeks, in the previous year and during lifetime. The DISC-IV is a fully-structured diagnostic interview that can be used by trained lay interviewers to assess mental disorders based on the definitions of the Diagnostic and Statistical Manual for Mental Disorders Fourth edition (DSM-IV). Only the relevant modules of the DISC-IV are conducted. The introductory module assesses sociodemographic characteristics and includes the construction of timelines of the previous year and the whole life based on life-events. Module A (anxiety disorders) includes questions about social phobia, separation anxiety, specific phobia, panic, agoraphobia, generalized anxiety, selective mutism, obsessive-compulsive behavior and post-traumatic stress. We added questions assessing fear of hypoglycemia. Module C (mood disorders) contains questions about major depression, dysthymia, and (hypo)mania. At baseline, module L (Whole Life) is also conducted to assess lifetime prevalence of mood and anxiety disorders.
When emotional problems are established as being present in the previous 4 weeks of assessment, we examine the course of these problems at follow-up. Based on the timeline constructed in the introductory module, adolescents are asked to report periods of remission and/or recurrence if applicable.
At all measurement occasions, adolescents complete the Children’s Depression Inventory 2 (CDI-2) and the Generalized Anxiety Disorder 7-item scale (GAD-7) which assess the self-reported severity of depression and anxiety symptoms during the previous 2 weeks [43,44,45]. As an additional indicator of mood problems in the adolescent, the parent report version of the Children’s Depression Inventory 2 is used .
Assessments of depression and anxiety in parents
At all three measurement occasions, parents/caregivers complete the Patient Health Questionnaire 9-item scale (PHQ-9) and Generalized Anxiety Disorder 7-item scale (GAD-7) to measure the severity of depression and anxiety symptoms in the previous 2 weeks [44, 46]. Both measures also have adequate psychometric properties to identify depression and anxiety disorders in adults (sensitivity 88 and 89%; specificity 88 and 82%, respectively) [44, 46].
Assessment of treatment for depression and anxiety
In the case of a positive screening result, the pediatricians of the research team are notified and inform the doctor caring for the adolescent in question. The description of treatment and follow-up (once the pediatrician has been informed of the presence of a mood or anxiety disorder) include:
- Reason(s) for not making a referral, e.g. watchful waiting, current treatment, self-reported need for (additional) care, decisions/preferences of adolescent and his/her family, previous treatment.
- Institution/health care provider to which a referral is made, waiting list period, treatment provided, decisions/preferences of adolescent and his/her family.
Assessment of other psychosocial and behavioral constructs
The Problem Areas in Diabetes Scale teen version (PAID-T) is used to assess diabetes-specific emotional distress in adolescents, which concerns negative emotions specifically related to living with diabetes and its self-management . For parents, the Problem Areas in Diabetes Scale parent revised version (PAID-PR) is used . Both adolescents and parents provide their perception of psychosocial problems during the previous 6 months (Strengths and Difficulties Questionnaire, SDQ, [49, 50]), following of diabetes care recommendations in the preceding month (Adherence in Diabetes Questionnaire, ADQ, ), and responsibility for different aspects of diabetes care (Diabetes Family Responsibility Questionnaire, DFRQ, ).
Sociodemographic and clinical data
Medical records provide information regarding the adolescent’s gender, age, most recent weight and height, age at diabetes diagnosis, diabetes duration, physical/psychiatric comorbidities, insulin treatment modality (multiple daily self-injections or continuous subcutaneous insulin infusion), lifetime HbA1c (i.e. composite of all HbA1c values during treatment in the diabetes clinic), the mean HbA1c in the past year and most recent HbA1c, glucose measurements and variability around the time of assessment (subsample only), diabetes-related hospitalisations, severe hypoglycemic events, and occurrence of diabetic ketoacidosis. Furthermore, the number of clinic visits, the number of other contacts (e.g. e-mail messages), cancelled visits, and no shows are extracted from medical records. Adolescents self-report their current educational level as part of the DISC-IV and physical/psychiatric comorbidities by completing a questionnaire. The questionnaire for parents includes items about their own gender, age, ethnic background, education, employment status, marital status, family socio-economic status, family composition, relation to the adolescent (e.g. biological parent, guardian), adolescent life-events, adolescent physical/psychiatric comorbidities, own history of mood/anxiety disorders, and current psychiatric problems in the family.
An overview of the measures included in diabetes LEAP is provided in Table 1
Informed consent is sought for (1) informing the pediatrician of study results in the case of a positive screen, (2) extracting clinical information from the medical record, and (3) using the data anonymously for scientific publications. The code of conduct issued by the national Central Committee on Research Involving Human Subjects (CCMO) relating to expressions of objection by minors participating in medical research is followed, as drafted by the Paediatric Association of The Netherlands (NVK). Adolescents are invited to enter a draw to win a tablet computer at each assessment round. Study visits are combined with usual care visits where possible; extra travel expenses are reimbursed.
Data handling and storage
The handling of personal data complies with the Dutch Personal Data Protection Act. Families are assigned a unique study number (unique successive numbers, starting with 11001). This number is used as the subject identification code in the anonymous study data file. The file containing the link between research codes and specific families is saved on a secure server and is only be accessed by people conducting the assessments. Psychology students assisting in the data collection sign a research contract, based on the Dutch Personal Data Protection Act. The anonymized data set is saved on a secure server. Data will be stored at this server for at least 15 years after the end of the study, in accordance with Tilburg University regulations.
Unless otherwise specified, statistical analyses will be performed using IBM SPSS Statistics v24, with significance level p < 0.05. The prevalence, course and treatment of emotional problems in adolescents with type 1 diabetes and their parents/caregivers (research aim #1 and #2) is established using descriptive statistics based on the sample at hand. Other analyses depend on the specific research questions and will be reported in detail in the papers concerned. These include logistic regression analysis (including a check of relevant assumptions) to examine which risk factors are associated with the occurrence of a mood and/or anxiety disorder (research aim #3) and longitudinal path modelling/structural equation modelling to examine the longitudinal relation between emotional problems and diabetes outcomes (research aim #4). To maximize the available data, the advanced Full Information Maximum Likelihood method will be applied to handle missing data. To get a sense of the required sample size, we posited a conservative logistic regression for the research question on risk factors for mood/anxiety disorders over the entire study period. As our study will be the first to determine the prevalence of these disorders in Dutch adolescents with type 1 diabetes, we calculated a range of sample sizes based on different cumulative event rates (175 to 400 required participants) . Taking into account statistical restrictions , non-response and loss to follow-up, we have to approach all families from all participating centers who meet the inclusion criteria and none of the exclusion criteria (n = 831).
The proposed prospective observational study will provide a much needed indication of the prevalence, course, risk factors and clinical impact of emotional problems among adolescents with type 1 diabetes and their parents/caregivers, thereby opening avenues for proper recognition, prevention and timely treatment. This may alleviate stress on scarce health care resources, making way for policy adjustments and re-allocation of funds. Diabetes LEAP will also shed more light on the current trajectories of psychological care after detection of emotional problems. A better understanding of the decision-making process will facilitate development and adjustments towards optimal care. By disentangling psychopathology and subclinical diabetes-specific distress, we also hope to assist policy makers in obtaining a better match between the problems at hand and mental health professionals and interventions. Diabetes LEAP will also provide an important contribution to the scientific literature, allowing comparisons with data from other countries and sharing of lessons learned.
Some potential limitations must also be acknowledged. Recruitment and preservation of participants in research is often challenging, and even more so in the case of adolescents and sensitive topics . Following previous recommendations to increase the response rate and reduce attrition, e.g. , we selected a research team with knowledge about diabetes and child psychology, involve paediatricians in the recruitment procedure, collaborate closely with site personnel, and offer proportional incentives for participation to families. To ensure sufficient power to conduct the longitudinal analyses, recruitment takes place in 8 paediatric diabetes clinics. However, sampling bias may occur if families experiencing emotional problems shy away from participation. Also, individuals who do not experience any problems might not feel inclined to participate. In an effort to minimize the risk of sampling bias and maximize the external validity of study results, the information package emphasized that participation in research is voluntary and that every adolescent/parent contribution is a valuable addition to the study. In order to limit attrition and support sustained commitment, we send participating families regular updates through clinic newsletters.
The data from this study will include results from psychiatric diagnostic interviews in a large cohort of adolescents with T1D in the Netherlands. We expect that it will further strengthen the scientific literature in this area, as we aim to provide much needed information regarding the scope of depression and anxiety in this group. This will hopefully contribute to better recognition, prevention and treatment of these problems and more optimal pediatric diabetes care.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Adherence in diabetes questionnaire
Children’s depression inventory 2
Diabetes family responsibility questionnaire
- Diabetes LEAP:
Longitudinal study of emotional problems in adolescents with type 1 diabetes and their parents
Diagnostic interview schedule for children
Diagnostic and statistical manual for mental disorders fourth edition
Generalized anxiety disorder 7-item scale
Paediatric Association of The Netherlands
Problem areas in diabetes scale parent revised version
Problem areas in diabetes scale teen version
Patient health questionnaire 9-item scale
Strengths and difficulties questionnaire
Type 1 diabetes
IDF. IDF Diabetes Atlas. 8th ed; 2017.
Diabetes in cijfers. https://www.diabetesfonds.nl/over-diabetes/diabetes-in-het-algemeen/diabetes-in-cijfers. Accessed 9 Jan 2019.
Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G, Group ES. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet. 2009;373(9680):2027–33.
Spaans EA, Gusdorf LM, Groenier KH, Brand PL, Veeze HJ, Reeser HM, Bilo HJ, Kleefstra N. The incidence of type 1 diabetes is still increasing in the Netherlands, but has stabilised in children under five (Young DUDEs-1). Acta Paediatr. 2015;104(6):626–9.
Delamater AM, de Wit M, McDarby V, Malik JA, Hilliard ME, Northam E, Acerini CL. ISPAD Clinical Practice Consensus Guidelines 2018: Psychological care of children and adolescents with type 1 diabetes. Pediatr Diabetes. 2018(19 Suppl 27):237–49.
Nathan DM, Group DER. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37(1):9–16.
Wood JR, Miller KM, Maahs DM, Beck RW, DiMeglio LA, Libman IM, Quinn M, Tamborlane WV, Woerner SE, Network TDEC. Most youth with type 1 diabetes in the T1D exchange clinic registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care. 2013;36(7):2035–7.
LA DM, Acerini CL, Codner E, Craig ME, Hofer SE, Pillay K, Maahs DM. ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 2018(19 Suppl 27):105–14.
Clements MA, Foster NC, Maahs DM, Schatz DA, Olson BA, Tsalikian E, Lee JM, Burt-Solorzano CM, Tamborlane WV, Chen V, et al. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry. Pediatr Diabetes. 2016;17(5):327–36.
Carlsen S, Skrivarhaug T, Thue G, Cooper JG, Goransson L, Lovaas K, Sandberg S. Glycemic control and complications in patients with type 1 diabetes - a registry-based longitudinal study of adolescents and young adults. Pediatr Diabetes. 2017;18(3):188–95.
Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M, Anderson B, Holzmeister LA, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005;28(1):186–212.
Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatr Clin North Am. 2009;32(3):483–524.
Thapar A, Collishaw S, Pine DS, Thapar AK. Depression in adolescence. Lancet. 2012;379(9820):1056–67.
Hilliard ME, De Wit M, Wasserman RM, Butler AM, Evans M, Weissberg-Benchell J, Anderson BJ. Screening and support for emotional burdens of youth with type 1 diabetes: strategies for diabetes care providers. Pediatr Diabetes. 2018;19(3):534–43.
Butwicka A, Frisen L, Almqvist C, Zethelius B, Lichtenstein P. Risks of psychiatric disorders and suicide attempts in children and adolescents with type 1 diabetes: a population-based cohort study. Diabetes Care. 2015;38(3):453–9.
Whittemore R, Kanner S, Singleton S, Hamrin V, Chiu J, Grey M. Correlates of depressive symptoms in adolescents with type 1 diabetes. Pediatr Diabetes. 2002;3(3):135–43.
Lawrence JM, Standiford DA, Loots B, Klingensmith GJ, Williams DE, Ruggiero A, Liese AD, Bell RA, Waitzfelder BE, McKeown RE, et al. Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for diabetes in youth study. Pediatrics. 2006;117(4):1348–58.
de Wit M, Snoek FJ. Depressive symptoms and unmet psychological needs of Dutch youth with type 1 diabetes: results of a web-survey. Pediatr Diabetes. 2011;12(3 Pt 1):172–6.
Fisher L, Hessler DM, Polonsky WH, Masharani U, Peters AL, Blumer I, Strycker LA. Prevalence of depression in type 1 diabetes and the problem of over-diagnosis. Diabet Med. 2016;33(11):1590–7.
Blanz BJ, Rensch-Riemann BS, Fritz-Sigmund DI, Schmidt MH. IDDM is a risk factor for adolescent psychiatric disorders. Diabetes Care. 1993;16(12):1579–87.
Kovacs M, Goldston D, Obrosky DS, Bonar LK. Psychiatric disorders in youths with IDDM: rates and risk factors. Diabetes Care. 1997;20(1):36–44.
Vila G, Robert JJ, Jos J, Mouren-Simeoni MC. Insulin-dependent diabetes mellitus in children and in adolescents: value of pedopsychiatric follow-up. Arch De Pediatrie. 1997;4(7):615–22.
Nakazato M, Kodama K, Miyamoto S, Sato M, Sato T. Psychiatric disorders in juvenile patients with insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 2000;48(3):177–83.
Northam EA, Matthews LK, Anderson PJ, Cameron FJ, Werther GA. Psychiatric morbidity and health outcome in type 1 diabetes--perspectives from a prospective longitudinal study. Diabet Med. 2005;22(2):152–7.
Colton PA, Olmsted MP, Daneman D, Rodin GM. Depression, disturbed eating behavior, and metabolic control in teenage girls with type 1 diabetes. Pediatr Diabetes. 2013;14(5):372–6.
Butwicka A, Fendler W, Zalepa A, Szadkowska A, Zawodniak-Szalapska M, Gmitrowicz A, Mlynarski W. Psychiatric disorders and health-related quality of life in children with type 1 diabetes mellitus. Psychosomatics. 2016;57(2):185–93.
Nguyen L, Nefs G, Pouwer F. Comment on Butwicka et al. psychiatric disorders and health-related quality of life in children with type 1 diabetes mellitus. Psychosomatics. 2017;58(2):214–5.
Anderson BJ, Vangsness L, Connell A, Butler D, Goebel-Fabbri A, Laffel LM. Family conflict, adherence, and glycaemic control in youth with short duration type 1 diabetes. Diabet Med. 2002;19(8):635–42.
Whittemore R, Jaser S, Chao A, Jang M, Grey M. Psychological experience of parents of children with type 1 diabetes: a systematic mixed-studies review. Diabetes Educ. 2012;38(4):562–79.
Beidel DC, Turner SM. At risk for anxiety: I. psychopathology in the offspring of anxious parents. J Am Acad Child Adolesc Psychiatry. 1997;36(7):918–24.
Shanahan L, Copeland W, Costello EJ, Angold A. Specificity of putative psychosocial risk factors for psychiatric disorders in children and adolescents. J Child Psychol Psychiatry Allied Discip. 2008;49(1):34–42.
Colletti CJ, Forehand R, Garai E, Rakow A, McKee L, Fear JM, Compas BE. Parent depression and child anxiety: an overview of the literature with clinical implications. Child Youth Care Forum. 2009;38(3):151–60.
Helgeson VS, Becker D, Escobar O, Siminerio L. Families with children with diabetes: implications of parent stress for parent and child health. J Pediatr Psychol. 2012;37(4):467–78.
Anderson B, Ho J, Brackett J, Finkelstein D, Laffel L. Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr. 1997;130(2):257–65.
Wiebe DJ, Chow CM, Palmer DL, Butner J, Butler JM, Osborn P, Berg CA. Developmental processes associated with longitudinal declines in parental responsibility and adherence to type 1 diabetes management across adolescence. J Pediatr Psychol. 2014;39(5):532–41.
Cameron FJ, Skinner TC, de Beaufort CE, Hoey H, Swift PG, Aanstoot H, Aman J, Martul P, Chiarelli F, Daneman D, et al. Are family factors universally related to metabolic outcomes in adolescents with type 1 diabetes? Diabet Med. 2008;25(4):463–8.
King PS, Berg CA, Butner J, Butler JM, Wiebe DJ. Longitudinal trajectories of parental involvement in type 1 diabetes and adolescents’ adherence. Health Psychol. 2014;33(5):424–32.
Eckshtain D, Ellis DA, Kolmodin K, Naar-King S. The effects of parental depression and parenting practices on depressive symptoms and metabolic control in urban youth with insulin dependent diabetes. J Pediatr Psychol. 2010;35(4):426–35.
Wiebe DJ, Gelfand D, Butler JM, Korbel C, Fortenberry KT, McCabe JE, Berg CA. Longitudinal associations of maternal depressive symptoms, maternal involvement, and diabetes management across adolescence. J Pediatr Psychol. 2011;36(7):837–46.
Mackey ER, Struemph K, Powell PW, Chen R, Streisand R, Holmes CS. Maternal depressive symptoms and disease care status in youth with type 1 diabetes. Health Psychol. 2014;33(8):783–91.
Cameron LD, Young MJ, Wiebe DJ. Maternal trait anxiety and diabetes control in adolescents with type 1 diabetes. J Pediatr Psychol. 2007;32(7):733–44.
Ferdinand RF, Van der Ende J. Nederlandse vertaling NIMH-DISC-IV. Rotterdam: Department of Child and Adolescent Psychiatry, Erasmus MC/Sophia Children’s Hospital; 2002.
Kovacs M. CDI 2: Children's depression inventory 2nd edition, Technical Manual. North Tonawanda: MHS; 2010.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.
Mossman SA, Luft MJ, Schroeder HK, Varney ST, Fleck DE, Barzman DH, Gilman R, DelBello MP, Strawn JR. The generalized anxiety disorder 7-item scale in adolescents with generalized anxiety disorder: signal detection and validation. Ann Clin Psychiatry. 2017;29(4):227–234A.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.
Weissberg-Benchell J, Antisdel-Lomaglio J. Diabetes-specific emotional distress among adolescents: feasibility, reliability, and validity of the problem areas in diabetes-teen version. Pediatr Diabetes. 2011;12(4 Pt 1):341–4.
Markowitz JT, Volkening LK, Butler DA, Antisdel-Lomaglio J, Anderson BJ, Laffel LM. Re-examining a measure of diabetes-related burden in parents of young people with type 1 diabetes: the problem areas in diabetes survey - parent revised version (PAID-PR). Diabet Med. 2012;29(4):526–30.
Goodman R, Meltzer H, Bailey V. The strengths and difficulties questionnaire: a pilot study on the validity of the self-report version. Eur Child Adolesc Psychiatry. 1998;7(3):125–30.
Becker A, Woerner W, Hasselhorn M, Banaschewski T, Rothenberger A. Validation of the parent and teacher SDQ in a clinical sample. Eur Child Adolesc Psychiatry. 2004;13(Suppl 2):II11–6.
Kristensen LJ, Thastum M, Mose AH, Birkebaek NH, Danish Society for Diabetes in C, Adolescence. Psychometric evaluation of the adherence in diabetes questionnaire. Diabetes Care. 2012;35(11):2161–6.
Anderson BJ, Auslander WF, Jung KC, Miller JP, Santiago JV. Assessing family sharing of diabetes responsibilities. J Pediatr Psychol. 1990;15(4):477–92.
Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods. 2009;41:1149-1160.
Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med. 2004;66(3):411–21.
Spigarelli M. Adolescent participation in research. J Adolesc Health. 2008;43(1):1–2.
Lamb J, Puskar KR, Tusaie-Mumford K. Adolescent research recruitment issues and strategies: application in a rural school setting. J Pediatr Nurs. 2001;16(1):43–52.
We thank all families and diabetes centers who participated in Diabetes LEAP.
This study was supported by a Dutch Diabetes Research Foundation Junior Fellowship granted to GN, with FP as senior researcher (2013.81.1645), after peer review. The funding source had no role in the design, data collection, analysis or interpretation of the study, or in the decision to submit the manuscript for publication.
Ethics approval and consent to participate
The study protocol was approved for all study sites by the Medical Ethics Committee of the Máxima Medical Center (48232.015.14). Families who agree to participate complete written informed consent. Adolescents can participate (with consent from parents/caregivers), even if the parent/caregiver him−/herself does not want to participate. The parent/caregiver cannot participate if the adolescent declines.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Nefs, G., Nguyen, L., Winterdijk, P. et al. Study protocol of Diabetes LEAP: a longitudinal study examining emotional problems in adolescents with type 1 diabetes and their parents/caregivers. BMC Pediatr 19, 377 (2019). https://doi.org/10.1186/s12887-019-1743-9
- Type 1 diabetes